35 related articles for article (PubMed ID: 7243210)
1. Pharmacokinetics of oral decongestants.
Kanfer I; Dowse R; Vuma V
Pharmacotherapy; 1993; 13(6 Pt 2):116S-128S; discussion 143S-146S. PubMed ID: 7507589
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.
Rawlins MD; Henderson DB; Hijab AR
Eur J Clin Pharmacol; 1977 Apr; 11(4):283-6. PubMed ID: 862649
[TBL] [Abstract][Full Text] [Related]
3. Pupillary Dilation in Research: More than Meets the Eye.
Szpernal J; Bachman Groth JA; Wynne N; Williams V; Spellecy R; Thuruthumaly C; Carroll J
Curr Eye Res; 2022 Jul; 47(7):965-977. PubMed ID: 35499263
[No Abstract] [Full Text] [Related]
4. Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation.
Szpernal J; Carroll J; Spellecy R; Bachman Groth JA
J Empir Res Hum Res Ethics; 2021; 16(1-2):54-64. PubMed ID: 33135560
[TBL] [Abstract][Full Text] [Related]
5. Over-the-Counter Ocular Decongestants in the United States - Mechanisms of Action and Clinical Utility for Management of Ocular Redness.
Hosten LO; Snyder C
Clin Optom (Auckl); 2020; 12():95-105. PubMed ID: 32801982
[TBL] [Abstract][Full Text] [Related]
6. Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective.
Davey K; Chang B; Purslow C; Clay E; Vataire AL
BMC Ophthalmol; 2018 Apr; 18(1):104. PubMed ID: 29673317
[TBL] [Abstract][Full Text] [Related]
7. Long Term and Intensive Use of Ophthalmic Topical Corticosteroids and the Risk of Positive Doping Test in Athletes: A Case Report.
Seif Barghi T; Kobarfard F; Hashemian A; Zebardast J
Asian J Sports Med; 2015 Sep; 6(3):e24621. PubMed ID: 26448853
[TBL] [Abstract][Full Text] [Related]
8. Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.
Grob SR; Gonzalez-Gonzalez LA; Daly MK
Clin Ophthalmol; 2014; 8():1281-9. PubMed ID: 25061276
[TBL] [Abstract][Full Text] [Related]
9. Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial.
Trinavarat A; Pituksung A
Indian J Ophthalmol; 2009; 57(5):351-4. PubMed ID: 19700872
[TBL] [Abstract][Full Text] [Related]
10. Systemic adverse effects of topical ophthalmic agents. Implications for older patients.
Diamond JP
Drugs Aging; 1997 Nov; 11(5):352-60. PubMed ID: 9359022
[TBL] [Abstract][Full Text] [Related]
11. Dilate the pupil and see the fundus.
Phillips CI
Br Med J (Clin Res Ed); 1984 Jun; 288(6433):1779-80. PubMed ID: 6428541
[No Abstract] [Full Text] [Related]
12. Non-prescription sympathomimetic agents and hypertension.
Chua SS; Benrimoj SI
Med Toxicol Adverse Drug Exp; 1988; 3(5):387-417. PubMed ID: 3057328
[TBL] [Abstract][Full Text] [Related]
13. Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes.
Chien DS; Schoenwald RD
Pharm Res; 1990 May; 7(5):476-83. PubMed ID: 2367315
[TBL] [Abstract][Full Text] [Related]
14. 3. Phenylephrine hydrochloride.
Meyer SM; Fraunfelder FT
Ophthalmology; 1980 Nov; 87(11):1177-80. PubMed ID: 7243210
[TBL] [Abstract][Full Text] [Related]
15. Possible adverse effects from topical ocular 10% phenylephrine.
Fraunfelder FT; Scafidi AF
Am J Ophthalmol; 1978 Apr; 85(4):447-53. PubMed ID: 655224
[No Abstract] [Full Text] [Related]
16. [Cardiovascular adverse effects due to phenylephrine eye drops in ophtalmic surgery].
Kauffmann S; Commun F; Schoeffler P; Souteyrand G; Chiambaretta F; Dewachter P
Ann Fr Anesth Reanim; 2013 Feb; 32(2):112-4. PubMed ID: 23375495
[TBL] [Abstract][Full Text] [Related]
17. Systemic reactions to ophthalmic drug preparations.
Fraunfelder FT; Meyer SM
Med Toxicol Adverse Drug Exp; 1987; 2(4):287-93. PubMed ID: 3306268
[TBL] [Abstract][Full Text] [Related]
18. Adverse systemic effects from pledgets of topical ocular phenylephrine 10%.
Fraunfelder FW; Fraunfelder FT; Jensvold B
Am J Ophthalmol; 2002 Oct; 134(4):624-5. PubMed ID: 12383833
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis.
Stavert B; McGuinness MB; Harper CA; Guymer RH; Finger RP
JAMA Ophthalmol; 2015 Jun; 133(6):647-52. PubMed ID: 25789577
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
